N
Noriko Sato
Researcher at Fujita Health University
Publications - 3
Citations - 114
Noriko Sato is an academic researcher from Fujita Health University. The author has contributed to research in topics: Monoclonal antibody & Cytotoxicity. The author has an hindex of 3, co-authored 3 publications receiving 103 citations.
Papers
More filters
Journal ArticleDOI
Comprehensive screening for antigens overexpressed on carcinomas via isolation of human mAbs that may be therapeutic
Gene Kurosawa,Yasushi Akahori,Miwa Morita,Mariko Sumitomo,Noriko Sato,Chiho Muramatsu,Keiko Eguchi,Kazuki Matsuda,Akihiko Takasaki,Miho Tanaka,Yoshitaka Iba,Susumu Hamada-Tsutsumi,Yoshinori Ukai,Mamoru Shiraishi,Kazuhiro Suzuki,Maiko Kurosawa,Sally Fujiyama,Nobuhiro Takahashi,Ryoichi Kato,Yoshikazu Mizoguchi,Mikihiro Shamoto,Hiroyuki Tsuda,Mototaka Sugiura,Yoshinobu Hattori,Shuichi Miyakawa,Ryoichi Shiroki,Kiyotaka Hoshinaga,Nobuhiro Hayashi,Atsushi Sugioka,Yoshikazu Kurosawa +29 more
TL;DR: It is likely that some of the Ags detected will become useful targets for the corresponding carcinoma therapy and that several mAbs will become therapeutic agents.
Journal ArticleDOI
Selection and analysis of anti-cancer antibodies for cancer therapy obtained from antibody phage library
Gene Kurosawa,Mariko Sumitomo,Yoshinori Ukai,Juvy Subere,Chiho Muramatsu,Keiko Eguchi,Miho Tanaka-Hashiba,Mai Sugiura,Misaki Ando,Noriko Sato,Miwa Morita,Kazuki Inaba,Satoko Morigaki,Akihiko Takasaki,Yasushi Akahori,Shuichi Miyakawa,Ichiro Uyama,Koutarou Maeda,Ryoichi Shiroki,Kiyotaka Hoshinaga,Yoshikazu Mizoguchi,Yoshinobu Hattori,Atsushi Sugioka,Mototaka Sugiura,Yoshikazu Kurosawa +24 more
TL;DR: It is concluded that identification of 488 mAb and the accumulated results of IHC analyses in this study could be the key for further therapeutic Ab against cancers.
Journal ArticleDOI
Methods for comprehensive identification of membrane proteins recognized by a large number of monoclonal antibodies
Gene Kurosawa,Mariko Sumitomo,Yasushi Akahori,Kazuki Matsuda,Chiho Muramatsu,Akihiko Takasaki,Yoshitaka Iba,Keiko Eguchi,Miho Tanaka,Kazuhiro Suzuki,Miwa Morita,Noriko Sato,Mototaka Sugiura,Atsushi Sugioka,Nobuhiro Hayashi,Yoshikazu Kurosawa +15 more
TL;DR: In order to isolate monoclonal antibodies (mAbs) that bind to tumor-associated antigens (Ags) they were individually screened by immunostaining, and clones that preferentially and strongly stained the malignant cells were chosen.